{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:58:26Z","timestamp":1770987506134,"version":"3.50.1"},"reference-count":77,"publisher":"FapUNIFESP (SciELO)","issue":"2 suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"DOI":"10.1590\/abd1806-4841.2019940208","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:53:45Z","timestamp":1559418825000},"page":"48-55","source":"Crossref","is-referenced-by-count":31,"title":["Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology"],"prefix":"10.1590","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-3639","authenticated-orcid":false,"given":"Everton Carlos Siviero do","family":"Vale","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2201-0387","authenticated-orcid":false,"given":"Oscar Cardoso","family":"Dimatos","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Catarina, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-4790","authenticated-orcid":false,"given":"Adriana Maria","family":"Porro","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-4254","authenticated-orcid":false,"given":"Claudia Giuli","family":"Santi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2019,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease","volume":"49","author":"Collin P","year":"2017","journal-title":"Ann Med"},{"key":"ref2","first-page":"1017","article-title":"Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation","volume":"64","author":"Bolotin D","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.det.2011.03.005","article-title":"Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation","volume":"29","author":"Cardones AR","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clindermatol.2011.03.010","article-title":"Dermatitis herpetiformis","volume":"30","author":"K\u00e1rp\u00e1ti S","year":"2012","journal-title":"Clin Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000347108","article-title":"Acral purpura as leading clinical manifestation of dermatitis herpetiformis: report of two adult cases with a review of the literature","volume":"227","author":"Tu H","year":"2013","journal-title":"Dermatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"g2557","DOI":"10.1136\/bmj.g2557","article-title":"Dermatitis herpetiformis","volume":"348","author":"Jakes AD","year":"2014","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.det.2011.03.019","article-title":"An exception within the group of autoimmune blistering diseases: dermatitis herpetiformis, the gluten-sensitive dermopathy","volume":"29","author":"K\u00e1rp\u00e1ti S","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ad.2010.06.018","article-title":"Clinical guidelines for the diagnosis and treatment of dermatitis herpetiformis","volume":"101","author":"Herrero-Gonz\u00e1lez JE","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2036.2008.03660.x","article-title":"No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study","volume":"27","author":"Lewis NR","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"ref10","first-page":"523","article-title":"Dermatitis herpetiformis: problems, progress and prospects","volume":"12","author":"Fry L","year":"2002","journal-title":"Eur J Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-4362.2003.01804.x","article-title":"Dermatitis herpetiformis","volume":"42","author":"Nicolas ME","year":"2003","journal-title":"Int J Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000372-200208000-00003","article-title":"Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features","volume":"24","author":"Warren SJ","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1468-3083.2009.03188.x","article-title":"Guidelines for the diagnosis and treatment of dermatites herpetiformis","volume":"23","author":"Caproni M","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-4632.2007.03214.x","article-title":"Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience","volume":"46","author":"Alonso-Llamazares J","year":"2007","journal-title":"Int J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CCID.S69127","article-title":"The diagnosis and treatment of dermatitis herpetiformis","volume":"8","author":"Antiga E","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2036.2008.03609.x","article-title":"Coeliac disease: a biopsy is not always necessary for diagnosis","volume":"27","author":"Hill PG","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.annder.2011.01.008","article-title":"Recommandations des centres de r\u00e9f\u00e9rence des maladies bulleuses auto-immunes pour le diagnostic et la prise en charge de la dermatite herp\u00e9tiforme. Dermatitis herpetiformis. Guidelines for the diagnosis and treatment","volume":"138","author":"Ingen-Housz-Oro S","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.det.2011.06.015","article-title":"Management of dermatitis herpetiformis","volume":"29","author":"Cardones AR","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2050640614559263","article-title":"The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis","volume":"3","author":"Ciacci C","year":"2015","journal-title":"United European Gastroenterol J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2133.1994.tb08557.x","article-title":"25 years experi\u00acence of a gluten-free diet in the treatment of dermatitis herpetiformis","volume":"131","author":"Garioch JJ","year":"1994","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2340\/0001555563129136","article-title":"Dermatitis herpetiformis: effect of gluten-restricted and gluten-free diet on dapsone requirement and on IgA and C3 deposits in uninvolved skin","volume":"63","author":"Ljunghall K","year":"1983","journal-title":"Acta Derm Venereol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.1982.tb00520.x","article-title":"Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal","volume":"107","author":"Fry L","year":"1982","journal-title":"Br J Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update","volume":"45","author":"Zhu YI","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2133.1993.tb00476.x","article-title":"Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance","volume":"129","author":"Coleman MD","year":"1993","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archderm.1992.01680120082007","article-title":"The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis","volume":"128","author":"Prussick R","year":"1992","journal-title":"Arch Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1345\/aph.1Q139","article-title":"Dapsone-induced methemoglobinemia: a primer for clinicians","volume":"45","author":"Barclay JA","year":"2011","journal-title":"Ann Pharmacother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2133.1995.tb05022.x","article-title":"Cimetidine improves the therapeutic\/toxic ratio of dapsone in patients on chronic dapsone therapy","volume":"132","author":"Rhodes LE","year":"1995","journal-title":"Br J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00403-013-1409-7","article-title":"Dapsone in dermatology and beyond","volume":"306","author":"Wozel G","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0190-9622(85)80416-3","article-title":"Dapsone is safe during pregnancy","volume":"13","author":"Kahn G","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"ref30","first-page":"1027","article-title":"Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis","volume":"64","author":"Bolotin D","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0190-9622(08)81054-7","article-title":"Sulfasalazine in dermatitis herpetiformis","volume":"22","author":"Goldstein BG","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1440-0960.2005.00152.x","article-title":"Sulfasalazine and dermatitis herpetiformis","volume":"46","author":"Willsteed E","year":"2005","journal-title":"Australas J Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archderm.1980.01640360047016","article-title":"Treatment of dermatites herpetiformis with colchicine","volume":"116","author":"Silvers DN","year":"1980","journal-title":"Arch Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0190-9622(08)80657-3","article-title":"Efficacy of cyclosporine in two patients with dermatitis herpetiformis resistant to conventional therapy","volume":"28","author":"Stenveld HJ","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2230.2000.00615.x","article-title":"Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide","volume":"25","author":"Shah SA","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0190-9622(08)81769-0","article-title":"Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone","volume":"28","author":"Zemtsov A","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S0004-28032013000200041","article-title":"Dermatitis herpetiformis, the celiac disease of the skin!","volume":"50","author":"Kotze LM","year":"2013","journal-title":"Arq Gastroenterol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jamadermatol.2016.4676","article-title":"Rituximab treatment for recalcitrant dermatitis herpetiformis","volume":"153","author":"Albers LN","year":"2017","journal-title":"JAMA Dermatol"},{"key":"ref39","first-page":"88","article-title":"Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis","volume":"18","author":"Marakli SS","year":"2008","journal-title":"Eur J Dermatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2133.2003.05579.x","article-title":"Long-term remission in patients with dermatitis herpetiformis on a normal diet","volume":"149","author":"Bardella MT","year":"2003","journal-title":"Br J Dermatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archdermatol.2010.336","article-title":"Remission in dermatitis herpetiformis: a cohort study","volume":"147","author":"Paek SY","year":"2011","journal-title":"Arch Dermatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2036.2012.04998.x","article-title":"The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study","volume":"35","author":"Grainge MJ","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2133.1996.tb01496.x","article-title":"Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis","volume":"135","author":"Lewis HM","year":"1996","journal-title":"Br J Dermatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1365-2133.2012.11105.x","article-title":"Reduced mortality in dermatitis herpetiformis: A population-based study of 476 patients","volume":"167","author":"Hervonen K","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050602","article-title":"Dermatitis Herpetiformis: A common extraintestinal manifestation of coeliac disease","volume":"10","author":"Reunala T","year":"2018","journal-title":"Nutrients"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0738-081X(00)00185-1","article-title":"Linear IgA Bullous Dermatosis","volume":"19","author":"Guide SV","year":"2001","journal-title":"Clin Dermatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1365-4362.1999.00813.x","article-title":"Linear IgA bullous dermatosis","volume":"38","author":"Egan CA","year":"1999","journal-title":"Int J Dermatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna G","year":"2012","journal-title":"Clin Dermatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D32TS975M4","article-title":"Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children","volume":"16","author":"Kharfi M","year":"2010","journal-title":"Dermatol Online J"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12026-017-8975-2","article-title":"Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations","volume":"66","author":"Kridin K","year":"2018","journal-title":"Immunol Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.131.8.957","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens D","year":"1995","journal-title":"Arch Dermatol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2133.1994.tb08491.x","article-title":"Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases","volume":"131","author":"Wojnarowska F","year":"1994","journal-title":"Br J Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2302\/kjm.51.21","article-title":"BP 180 as the common autoantigen in blistering disease with different clinical phenotypes","volume":"51","author":"Zillikens D","year":"2002","journal-title":"Keio J Med"},{"key":"ref54","series-title":"Dermatology","first-page":"648","volume-title":"Blistering diseases","author":"Braun-Falco O","year":"2000","edition":"2 ed"},{"key":"ref55","first-page":"49","article-title":"Linear IgA dermatosis induced by pregnancy","volume":"83","author":"Kanagusuko T","year":"2008","journal-title":"An Bras Dermatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mjd.2001.117518","article-title":"Immunofluorescence in dermatology","volume":"45","author":"Mutasim DF","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1346-8138.2001.tb00056.x","article-title":"Clinical Spectrum, Pathogenesis and Treatment of Linear IgA Bullous Dermatosis","volume":"28","author":"Zone JJ","year":"2001","journal-title":"J Dermatol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1365-2133.1999.02904.x","article-title":"The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis","volume":"140","author":"Caproni M","year":"1999","journal-title":"Br J Dermatol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal J","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0190-9622(03)02120-0","article-title":"UV light-induced linear IgA dermatoses","volume":"50","author":"Salmhofer W","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"ref61","series-title":"Rook's Textbook of Dermatology","first-page":"40","volume-title":"Immunobullous diseases","author":"Wojnarowska F","year":"2010","edition":"8th ed"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/abd1806-4841.20187304","article-title":"Adult linear IgA bullous dermatosis: report of three cases","volume":"93","author":"Machado TYS","year":"2018","journal-title":"An Bras Dermatol"},{"key":"ref63","series-title":"Dermatoses Bolhosas Autoimunes","first-page":"85","volume-title":"Dermatose Bolhosa por IgA Linear","author":"Miyamoto D","year":"2016"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.iac.2012.04.004","article-title":"Linear IgA Disease: Clinical Presentation, Diagnosis, and Pathogenesis","volume":"32","author":"Venning VA","year":"2012","journal-title":"Immunol Allergy Clin N Am"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1365-4632.2011.05138.x","article-title":"A further case of subacute prurigo-like linear IgA bullous dermatoses: growing evidence of a new subset","volume":"51","author":"Antiga E","year":"2012","journal-title":"Int J Dermatol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archderm.142.6.786","article-title":"Ocular linear IgA disease resulting in blindness","volume":"142","author":"Talhari C","year":"2006","journal-title":"Arch Dermatol"},{"issue":"Suppl 1","key":"ref67","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1590\/abd1806-4841.20164665","article-title":"Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis","volume":"91","author":"Pereira AR","year":"2016","journal-title":"An Bras Dermatol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1590\/abd1806-4841.20143221","article-title":"Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience","volume":"89","author":"Arbache ST","year":"2014","journal-title":"An Bras Dermatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1590\/S0365-05962010000400010","article-title":"Imunofluoresc\u00eancia direta e indireta","volume":"85","author":"Aoki V","year":"2010","journal-title":"An Bras Dermatol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0738-081X(00)00179-6","article-title":"Direct immunofluorescence microscopy in the diagnosis of autoimune bullous dermatoses","volume":"19","author":"Morrison LH","year":"2001","journal-title":"Clin Dermatol"},{"issue":"Suppl 1","key":"ref71","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1590\/abd1806-4841.20132154","article-title":"Dermatose por IgA linear - relato de um caso exuberante","volume":"88","author":"Souza BC","year":"2013","journal-title":"An Bras Dermatol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.det.2011.06.014","article-title":"Management of Linear IgA Disease","volume":"29","author":"Ng SY","year":"2011","journal-title":"Dermatol Clin"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-4362.2002.01321.x","article-title":"Localized linear IgA disease responding to colchicine","volume":"41","author":"Benbenisty KM","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1525-1470.1999.99015.x","article-title":"Treatment of linear IgA bullous dermatosis of childhood with colchicine","volume":"16","author":"Ang P","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2230.2002.01133.x","article-title":"Linear IgA disease: successful treatment with erythromycin","volume":"27","author":"Cooper SM","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0190-9622(08)80585-3","article-title":"Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide","volume":"26","author":"Peoples D","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"ref77","first-page":"562","article-title":"Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders","volume":"151","author":"Lozinski A","year":"2012","journal-title":"Harefuah"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v94n2s1\/0365-0596-abd-94-02-s1-0048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:46Z","timestamp":1747666846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962019000700048&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":77,"journal-issue":{"issue":"2 suppl 1","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["S0365-05962019000700048"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.2019940208","relation":{},"ISSN":["1806-4841","0365-0596"],"issn-type":[{"value":"1806-4841","type":"electronic"},{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}